Lung Cancer HELPLine 844-360-5864
Cardinale Smith, MD, PhD, oncologist and associate professor at the Icahn School of Medicine at Mt. Sinai, explains how shared decision-making with one's healthcare team can create a treatment plan that aligns with the patient's goals.
This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
Palliative care is supportive care that anticipates, prevents, and treats the symptoms and side effects of the disease and its treatment. It is intended to improve one's quality of life and can be addressed at any stage from diagnosis forward.
This webinar features Estelamari Rodriguez, MD, MPH, thoracic oncologist at the Sylvester Comprehensive Cancer Center at the University of Miami. This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
An online panel discussion offers real-world suggestions and examples for ways to get the care and support you need. The discussion features Angela James, LUNGevity care navigator; Lavern McDonald, a teacher living with lung cancer; and Patricia Simmers, a nurse navigator. The panelists share their personal stories, challenges, and lessons learned through their journeys with lung cancer. This panel discussion was hosted by LUNGevity in collaboration with Novartis.
Every fall, the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong.
November is Lung Cancer Awareness Month – a time to come together to celebrate the strength of the lung cancer community.
Whether you are newly diagnosed or a long-term survivor, LUNGevity offers lung cancer support and survivorship services to address your unique needs. LUNGevity's services are designed to help you feel supported, informed, and empowered to be an active decision-maker in your treatment process and live well with the disease.
For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000 people in the US are diagnosed with lung cancer. The high incidence of lung cancer means scientific research into new therapies is critical, both for current survivors and those who will be diagnosed in the future. Thankfully, the landscape of lung cancer is changing for the better.
